Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,571 across all filing types
Latest filing 2023-05-24 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2023-05-24 English
Regulatory Filings 2023
Regulatory Filings
2023-05-22 English
DFAN14A
Proxy Solicitation & Information Statement
2023-05-19 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing with the SEC, specifically labeled as a "Definitive Additional Materials" related to a proxy statement for Illumina, Inc.'s 2023 Annual Meeting of Stockholders. It contains a letter from the Board Chair urging shareholders to vote for the company's director nominees and discusses board refreshment, governance, and shareholder voting instructions. The content focuses on proxy solicitation and shareholder voting information rather than the actual proxy statement or annual report itself. The presence of detailed voting instructions and solicitation material aligns with the definition of Proxy Solicitation & Information Statement filings. Therefore, the document is best classified as a Proxy Solicitation & Information Statement (PSI).
2023-05-18 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as "Definitive Additional Materials" related to a proxy statement for Illumina, Inc. The content includes detailed discussion about corporate governance issues, shareholder activism, and regulatory inquiries, which are typical topics covered in proxy statements and related materials. The document is not an annual report, earnings release, or other financial report but rather materials related to shareholder voting and corporate governance matters. Therefore, the filing type corresponds to Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and detailed content confirm it is the actual filing, not just an announcement or certification.
2023-05-17 English
Remuneration Information 2023
Remuneration Information Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive additional proxy statement material related to the company's Annual Meeting of Stockholders. It discusses the qualifications of director nominees, opposition to a shareholder activist's nominees, and requests shareholders to vote for the company's slate of directors. The content focuses on board composition, governance, and proxy solicitation matters. It is not the proxy statement itself but additional materials related to proxy solicitation. Given the SEC form type DEFA14A and the content, this document fits the Remuneration Information (DEF 14A) category, which includes reports detailing compensation and proxy-related information for directors and executives. The document is lengthy and substantive, not a brief announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is DEF 14A with high confidence.
2023-05-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.